Heparin is a blood-thinning medication used to prevent and treat blood clots. It works faster than oral anticoagulants, making it the go-to choice in hospitals for emergencies like pulmonary embolism, during surgeries that require blood to flow through machines, and for patients at risk of dangerous clotting. It’s one of the most widely used anticoagulants in medicine, and understanding its applications can help you make sense of why it was prescribed or recommended.
How Heparin Prevents Clots
Heparin doesn’t dissolve clots that already exist. Instead, it stops new ones from forming and prevents existing ones from growing. It does this by activating a natural protein in your blood called antithrombin, which normally works slowly on its own. When heparin binds to antithrombin, it dramatically speeds up the protein’s ability to shut down two key players in the clotting process: thrombin and factor Xa.
Thrombin is the enzyme that converts a dissolved blood protein into fibrin, the stringy mesh that forms the structural backbone of a clot. By blocking thrombin, heparin prevents fibrin from forming and also stops thrombin from activating platelets (the cell fragments that clump together to build clots). The result is a powerful brake on the entire clotting cascade, which is why heparin can be effective within minutes of entering the bloodstream.
Treating and Preventing Blood Clots
The most common reason you’ll encounter heparin is for venous thromboembolism, which includes deep vein thrombosis (DVT) and pulmonary embolism (PE). DVT occurs when a clot forms in a deep vein, usually in the leg. If that clot breaks loose and travels to the lungs, it becomes a PE, which can be life-threatening. Heparin is used both to treat these conditions once they’re diagnosed and to prevent them in people at high risk, such as patients recovering from surgery or those confined to bed rest for extended periods.
For prevention in hospitalized patients, heparin is often given as a small injection under the skin every 8 to 12 hours. This low, fixed dose is enough to reduce clotting risk without requiring intensive monitoring. For active treatment of a confirmed clot, the dose is much higher and delivered through an IV, with blood tests used to make sure the level stays in the right therapeutic range.
Heart Attacks and Unstable Angina
Heparin plays a critical role in cardiac emergencies. During a heart attack, clots form inside the coronary arteries that supply blood to the heart muscle. Heparin helps prevent those clots from expanding while other treatments (like clot-busting drugs or procedures to open blocked arteries) take effect. It’s also standard therapy for unstable angina, a condition where reduced blood flow to the heart causes chest pain that’s worsening or occurring at rest, signaling that a heart attack may be imminent.
After a heart attack, heparin is sometimes continued to prevent mural thrombus, a clot that can form on the damaged inner wall of the heart. If a piece of that clot breaks off, it can travel to the brain and cause a stroke.
Use During Surgery and Medical Procedures
Open-heart surgery requires a machine to temporarily take over the work of the heart and lungs. Blood flowing through this machine’s tubing and filters would clot almost immediately without anticoagulation. Heparin is the standard drug for this purpose because it acts fast, its effect can be precisely monitored during the operation, and it can be reversed at the end of surgery with a drug called protamine. Surgeons typically aim for a clotting time of 400 to 500 seconds (compared to a normal range of about 70 to 120 seconds) before putting a patient on the bypass machine.
A similar principle applies during dialysis. When blood leaves the body and circulates through a dialysis machine, clotting inside the circuit can cause the loss of 180 to 200 mL of blood that can’t be returned to the patient. It also reduces how effectively the machine cleans waste from the blood. For this reason, heparin is routinely given at the start of each dialysis session to keep the circuit running smoothly.
Heparin in Pregnancy
Pregnant women who need anticoagulation present a unique challenge because many blood thinners can cross the placenta and harm the developing baby. Heparin, both the standard (unfractionated) form and the low-molecular-weight version, does not cross the placenta. This makes it one of the few anticoagulants considered safe during pregnancy. It’s used for pregnant women with clotting disorders, a history of blood clots, certain heart valve replacements, or recurrent pregnancy complications linked to abnormal clotting.
Unfractionated vs. Low-Molecular-Weight Heparin
When people say “heparin,” they usually mean unfractionated heparin (UFH), which is a mix of molecules in various sizes. Low-molecular-weight heparin (LMWH) is a refined version made of smaller molecules. The two forms work through the same basic mechanism but differ in practical ways that matter for patients.
UFH is given by IV or injection and requires regular blood tests to keep the dose in the right range. Its effects wear off quickly, which is an advantage in hospitals where doctors may need to stop anticoagulation fast, for example before an emergency procedure. LMWH is more predictable. It’s injected under the skin once or twice a day and usually doesn’t require monitoring, making it easier to use at home. For surgical patients, both forms are effective at preventing clots, and in some cases UFH is the more cost-effective option. In trauma patients, UFH given three times daily has shown similar effectiveness to LMWH for clot prevention, with meaningful cost savings.
Monitoring During Treatment
When heparin is used at treatment doses (not just for prevention), your medical team will check your blood regularly using a test called the activated partial thromboplastin time, or aPTT. This test measures how long it takes your blood to clot in a lab setting. The typical target is 1.5 to 2.5 times longer than normal, though some laboratories use a range of 2.0 to 3.5 times normal depending on their specific testing equipment. These checks ensure the dose is high enough to be effective but not so high that it causes dangerous bleeding.
Risks and Side Effects
The most obvious risk of any blood thinner is bleeding. Bruising at injection sites is common and usually harmless. More serious bleeding, such as blood in the urine or stool, prolonged nosebleeds, or unusual bruising, warrants immediate attention.
The most significant complication unique to heparin is heparin-induced thrombocytopenia, or HIT. This occurs in roughly 0.3% to 5% of patients, depending on the type of heparin used and the patient population. HIT is counterintuitive: your immune system forms antibodies against a complex of heparin and a platelet protein, which paradoxically activates platelets instead of calming them. The result is a drop in platelet count (thrombocytopenia) combined with an increased risk of dangerous clots in both arteries and veins. The clotting risk, not the low platelet count, is the major concern. If HIT is suspected, heparin is stopped immediately and replaced with an alternative anticoagulant.
Long-term heparin use (weeks to months) can also lead to bone loss, which is one reason doctors prefer to transition patients to other anticoagulants when extended treatment is needed.